BioLine Rx BLRX reported its Q1 earnings results on Wednesday, May 11, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
BioLine Rx beat estimated earnings by 33.33%, reporting an EPS of $-0.1 versus an estimate of $-0.15.
Revenue was down $0.00 from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.04 which was followed by a 4.73% increase in the share price the next day.
To track all earnings releases for BioLine Rx visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.